Schonfeld Strategic Advisors LLC

Position in ANIP — Ani Pharmaceuticals Inc

CIK 1665241 NEW YORK, NY

Back to ANIP Full portfolio

Position in ANIP

as of Jun 30, 2026 · filed Aug 14, 2026 Compact

Position Value

$3,411,943

-$10,862,927 QoQ

Shares Held

41,217

-77.8% QoQ

Ownership

0.179%

of shares outstanding

% of Portfolio

0.02%

of 13F equity value

Holder Rank

#85

of 303 holders

Holding Since

Dec 2022

11 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Common Shares in ANIP Over Time

Shares Held

Position Value (USD)

Position in Drug Manufacturers - Specialty & Generic

Healthcare · as of Jun 30, 2026

Schonfeld Strategic Advisors LLC holds $64,099,635 across 21 Drug Manufacturers - Specialty & Generic names. ANIP ranks #7 (5.3% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	HROW	Harrow, Inc.	319,625	$13,574,473
2	ALKS	Alkermes plc.	195,174	$10,227,117
3	BCRX	Biocryst Pharmaceuticals Inc	710,816	$7,108,160
4	INDV	Indivior Pharmaceuticals, Inc.	130,982	$5,374,191
5	AMRX	Amneal Pharmaceuticals, Inc.	305,991	$5,296,704
6	ZTS	Zoetis Inc.	63,752	$4,581,218
7	ANIP	Ani Pharmaceuticals Inc This page	41,217	$3,411,943
8	HLN	Haleon plc	363,872	$3,394,925

All Filings in ANIP

Export CSV

11 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$3,411,943	41,217	-77.8%	Shares	Sole	2026-08-14
2026-03-31	$14,274,870	185,629	-3.3%	Shares	Sole	2026-05-15
2025-12-31	$15,156,953	192,006	+780.8%	Shares	Sole	2026-02-17
2025-09-30	$1,996,880	21,800	-41.9%	Shares	Sole	2025-11-14
2025-06-30	$2,450,007	37,548	-49.9%	Shares	Sole	2025-08-14
2025-03-31	$5,020,714	74,992	+1857.5%	Shares	Sole	2025-05-15
2023-12-31	$211,241	3,831	-88.0%	Shares	Sole	2024-02-14
2023-09-30	$1,846,308	31,800	-36.4%	Shares	Sole	2023-11-14
2023-06-30	$2,691,500	50,000	+68.1%	Shares	Sole	2023-08-14
2023-03-31	$1,181,670	29,750	-25.3%	Shares	Sole	2023-05-15
2022-12-31	$1,603,004	39,846	—	Shares	Sole	2023-02-14
No filing history on record for this holder in this stock.